PPT-Cyclin-Dependent Kinase 12 as a Therapeutic Target in the Treatment of Breast Cancer
Author : isabella2 | Published Date : 2024-02-02
Gavin Buckley Supervisor Dr Malgorzata Krajewska School of Biochemistry and Cell Biology University College Cork 1 Transcriptional CyclinDependent Kinases CDK12
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Cyclin-Dependent Kinase 12 as a Therapeu..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Cyclin-Dependent Kinase 12 as a Therapeutic Target in the Treatment of Breast Cancer: Transcript
Gavin Buckley Supervisor Dr Malgorzata Krajewska School of Biochemistry and Cell Biology University College Cork 1 Transcriptional CyclinDependent Kinases CDK12 Promotes transcription elongation. Kinase. Inhibitors. Charles Harrell. Outline of Material Presented. Definition of Cancer. Understanding . Kinases. Kinase. Inhibitor Functionality. Economic Considerations. Assigned Reading. Homework Questions. October 25,2017. Disclosures. None. Outline. Epidemiology. Risk Factors. Screening. Diagnosis. Treatment. Genetic testing. Research. Epidemiology. 2017 :estimated 252.710 new cases of invasive breast cancer in women. Jennifer M. Matro, MD. Rena Rowan Breast Center. Abramson Cancer Center. University of Pennsylvania. Overview. What is metastatic breast . c. ancer (MBC)?. Who is at risk?. Subtypes of Breast Cancer. Julie R. Gralow, M.D.. Director, Breast Medical Oncology. Jill Bennett Endowed Professor of Breast Cancer. Professor, Global Health. University of Washington School of Medicine. Fred Hutchinson Cancer Research Center. Kinections. Map P24941 . CDK2. P24941. +Y179. +T160. S46. -Y15. -T14. -Y168. Akt1/. PKBa. P31749. Wee1. P30291. CDK7. P50613. -T165. +Y159. +T158. T39. Lyn. P07948. ERK1/MAPK3. P27361. ERK2/MAPK1. P28482. Lawrence B. Marks, M.D.Professor and ChairmanUniversity of North Carolina at Chapel Hill, NC ��UNC Varian Medical: grant, speakerSiemans Medical: grantNIH, Lance Armstrong: grants Discla Steven J. Katz MD MPH. Professor of Medicine and Health Management and Policy. University of Michigan . Allison Kurian MD M Sc.. Professor of Medicine and Medical Genetics . Stanford University . Guidelines 2019. Cleveland Clinic Florida. Breast Surgeon . September 25, 2018. Breast Cancer . Highly prevalent disease . Limited to female sex in all but < 1% of cases in USA. SEER . Cancer. . Stat Facts: Female Breast Cancer. Kinections. Map Q00535 . CDK5. Q00535. -Y167. +S159. +Y158. -Y15. -Y14. Abl1. P00519. Fyn. P06241. TrkA. /NTRK1. P04629. CDK7. P50613. CK1. a. 1/CSNK1A1. P48729. -T138. CDK5R1/p35. Q15078. T197. S170. is disease characterized by uncontrolled cell growth. . Characteristics of Cancer Cells:. 1. ) Lack of Differentiation . . Differentiation. is the process of cellular development by which a cell acquires a specific structure and function. . . Vinita Agarwal, PhD. Salisbury University USA. Virtual Poster Presentation (PowerPoint) to the . Global Approaches of Integrative Oncology. session at the . National Cancer Institute, Trans NCI-NIH Conference on International Perspectives on Integrative Medicine for Cancer Prevention and Cancer Patient Management,. breast tissue, . most . commonly from the inner lining . of. milk ducts or the lobules that supply the . ducts . with . milk.. Breast cancer may be invasive or noninvasive. . Invasive. It is the growth and division of single cell into daughter cells and duplication (replication).. In . prokaryotic cells, . the cell cycle occurs via process termed binary fission.. In . eukaryotic cells, . Camryn Tims, Rajib Biswas, Treiveanna Jenkins, Anup Kundu PhD.. Biology Department, Xavier University; Tulane University Health Sciences Center. In this project, the MDR proteins will be targeted as the major resistant protein in the cancer cell lines. When MRP-1/P-.
Download Document
Here is the link to download the presentation.
"Cyclin-Dependent Kinase 12 as a Therapeutic Target in the Treatment of Breast Cancer"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents
